Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar;38(3):819-829.
doi: 10.1007/s11011-023-01188-5. Epub 2023 Mar 2.

Neuroinflammation in Alzheimer's disease: potential beneficial effects of vitamin D

Affiliations
Review

Neuroinflammation in Alzheimer's disease: potential beneficial effects of vitamin D

Bruna R Kouba et al. Metab Brain Dis. 2023 Mar.

Abstract

Alzheimer's disease (AD) is the most common cause of dementia. In recent years, several studies have robustly shown that neuroinflammation plays a crucial role in the pathophysiology of this disease. The co-localization of amyloid-β plaques near activated glial cells and the increased levels of inflammatory cytokines in AD patients indicate the involvement of the neuroinflammatory process in AD progression. Considering that pharmacological treatment remains a challenge for the management of this disease, compounds with anti-inflammatory and antioxidant properties are promising therapeutic strategies. In this context, vitamin D has gained attention in the last few years due to its neuroprotective property and the high prevalence of vitamin D deficiency in the population. Herein, in this narrative review we present the possible contribution of the antioxidant and anti-inflammatory properties of vitamin D for its neuroprotective effects, and the clinical and preclinical data dealing with the effects of vitamin D in AD, focusing mainly on the neuroinflammatory process.

Keywords: Alzheimer’s disease; Anti-inflammatory effect; Antioxidant effect; Neuroinflammation; Vitamin D.

PubMed Disclaimer

References

    1. Ali A, Shah SA, Zaman N et al (2021) Vitamin D exerts neuroprotection via SIRT1/nrf-2/ NF-kB signaling pathways against D-galactose-induced memory impairment in adult mice. Neurochem Int 142:104893. https://doi.org/10.1016/j.neuint.2020.104893 - DOI - PubMed
    1. Annweiler C, Brugg B, Peyrin J-M et al (2014) Combination of memantine and vitamin D prevents axon degeneration induced by amyloid-beta and glutamate. Neurobiol Aging 35:331–335. https://doi.org/10.1016/j.neurobiolaging.2013.07.029 - DOI - PubMed
    1. Annweiler C, Herrmann FR, Fantino B et al (2012) Effectiveness of the combination of Memantine Plus vitamin D on cognition in patients with Alzheimer Disease: a Pre-Post Pilot Study. Cogn Behav Neurol 25:121–127. https://doi.org/10.1097/WNN.0b013e31826df647 - DOI - PubMed
    1. Annweiler C, Llewellyn DJ, Beauchet O (2013) Low serum vitamin D concentrations in Alzheimer’s Disease: a systematic review and Meta-analysis. J Alzheimers Dis 33:659–674. https://doi.org/10.3233/JAD-2012-121432 - DOI - PubMed
    1. Baeke F, Takiishi T, Korf H et al (2010) Vitamin D: modulator of the immune system. Curr Opin Pharmacol 10:482–496. https://doi.org/10.1016/j.coph.2010.04.001 - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources